Medpace Poland

Company description

Established in 1992, Medpace partners with leading pharmaceutical, biotechnology, and medical device companies to bring promising new drugs to market. As a full-service Clinical Research Organization (CRO), we combine efficient clinical trial management, comprehensive regulatory consulting, and innovative technologies to create a customized approach that ensures powerful solutions for our partners around the globe.

Products and services

Clinical Operations – including regulatory submissions, investigator selection, clinical monitoring, and clinical trial management.
Medical Writing & Reviewing – including Marketing Approval Applications and New Drug Applications (NDA).
Biometrics – including Data Management, Electronic Data Capture (EDC), and Biostatistics.
Regulatory Support – including protocol planning and strategic development plans.
Quality Assurance – including validation compliance and auditing.
Pharmacovigilance – comprehensive identification and assessment of risk during clinical trials.
Interactive Voice Response System (IVRS) – our proprietary system is web and phone interchangeable.
Medpace Reference Laboratories (MRL) – a state-of-the-art, full-service, central laboratory providing Phase I/IIa confined and controlled clinical studies.
Medpace Bioanalytical Laboratories – obtain accurate, high-quality results with complete bioanalytical laboratory services.
Medpace Cardiovascular Core Laboratory – state-of-the art, ECG technologies and centralized electrocardiography data analysis to support Phase I-IV clinical trials.
Imagepace – a centralized core imaging laboratory.
Medpace Clinical Pharmacology (CPU) – a state-of-the-art recruitment and diagnostic facility.
Pharmacokinetics & Pharmacodynamics – complete analysis of drug concentration and drug response.